Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Phenotyping Alzheimer's disease with blood tests

Blennow, Kaj · 2021 · Science

Abstract

Affordable and accessible tools could be used for screening and therapy monitoring

Overview

Integrity signals

Registry

Crossref · 10.1126/science.abi5208

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Research works printed but not linked: 1

  1. A. Keshavan , Brain 144, 434 (2021).

Cited by

See all 41

Metadata

Authors
Blennow, K.
Affiliations
University of Gothenburg (SE)
Corresponding author
Blennow, Kaj
Venue
Science
Published
2021-08-06
Volume
373
Issue
6555
Pages
626-628
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3191044320
Cited by
41
References
15
Citations by year
2026: 3 · 2025: 9 · 2024: 7 · 2023: 7 · 2022: 14 · 2021: 1
FWCI
5.20
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
Alzheimer's disease, blood analysis, phenotyping, biomarkers, disease screening, treatment monitoring, liquid biopsy
MeSH terms
Alzheimer Disease, Humans, Peptide Fragments, Phenotype, Phosphorylation, Biomarkers, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, tau Proteins, Positron-Emission Tomography, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phenotyping Alzheimer's disease with blood tests. https://app.cochat.ai/papers/10.1126/science.abi5208
The paper
Blennow, K. (2021). Phenotyping Alzheimer's disease with blood tests. Science. https://doi.org/10.1126/science.abi5208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.